iSpecimen Inc.
ISPC
$0.42
-$0.06-13.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -85.05% | -32.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -85.05% | -32.57% | |||
| Cost of Revenue | -53.94% | -32.42% | |||
| Gross Profit | -136.43% | -32.78% | |||
| SG&A Expenses | 40.34% | 4.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.87% | -5.98% | |||
| Operating Income | -55.39% | -11.17% | |||
| Income Before Tax | -165.53% | 36.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -165.53% | 36.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -165.53% | 36.85% | |||
| EBIT | -55.39% | -11.17% | |||
| EBITDA | -57.44% | -11.63% | |||
| EPS Basic | -13.54% | 41.25% | |||
| Normalized Basic EPS | -13.54% | 41.26% | |||
| EPS Diluted | -13.54% | 41.25% | |||
| Normalized Diluted EPS | -13.54% | 41.26% | |||
| Average Basic Shares Outstanding | 133.87% | 7.48% | |||
| Average Diluted Shares Outstanding | 133.87% | 7.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||